Clinical Trials Browser

Breast Neoplasms × Platinum × 30 days × Clear all

NCT06351332 2026-06-04

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Phase 1 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms